Effect of repeated subcutaneous administration of growth hormone releasing factor (GRF 1-44) on hypophysis in GH-deficient children.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006130:Growth Disorders / Q000209:etiology* / Q000503:physiopathology; D013006:Growth Hormone / Q000097:blood / Q000172:deficiency*; D013007:Growth Hormone-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D010446:Peptide Fragments / Q000008:administration & dosage; D010902:Pituitary Gland / Q000187:drug effects* / Q000503:physiopathology; D011388:Prolactin / Q000097:blood
D010446:Peptide Fragments; C040786:somatotropin releasing hormone (1-44)amide; D011388:Prolactin; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone